TENX compared with OCGN: revenue, margins and what each company keeps, and the suppliers and customers both name

TENXTenax Therapeutics, Inc.

Mkt capRevenueRevenue

OCGNOcugen, Inc.

Mkt capRevenueRevenue

Compare

TENXTenax Therapeutics, Inc.

OCGNOcugen, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

TENX1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−9.27%—

OCGN1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±22.9%▼−3.13%×0.14

= impliedTENX realized, solidOCGN realized, hatchedOne scale, both sides: full bar = 23%× = |realized| ÷ impliedSource: market data

TENXTenax Therapeutics, Inc.

1.80· pre 1.80· delayed

Mkt cap$67.0MRevenue—Revenue—

OCGNOcugen, Inc.

0.71· pre 0.73· delayed

Pre-marketNov 2 '26delayed

Mkt cap$238.3MRevenue$1MQ2 FY26Revenue$4MFY24

Compare

Pre-marketNov 2 '26delayed

TENXTenax Therapeutics, Inc.

OCGNOcugen, Inc.

1.80pre 1.80delayed

Price

0.71pre 0.73delayed

$67.0M

Mkt cap

$238.3M

—

Revenue

$1MQ2 FY26

—

Revenue

$4MFY24

TENX1.80vsOCGN0.71Pre-marketNov 2 '26delayed